To ask the Secretary of State for Health and Social Care, what discussions he has had with industry and academic partners on reducing barriers to commercialisation of cancer research.
Answered on
26 April 2022
We engage regularly with academia and industry regarding the ambitions contained in the Life Sciences Vision. This includes the development and commercialisation of new cancer medicines, diagnostics and genomic and predictive technologies in the United Kingdom.
The National Institute for Health and Care Research’s (NIHR) Intellectual Property Unit aims to develop the capacity of researchers to enter into commercial partnerships with relevant organisations; provide support and advice on processes and intellectual property management to facilitate commercialisation of new research and technologies. The NIHR also provides funding for studies through the Invention for Innovation Programme, to reduce the risks for innovations which have potential for commercialisation.